Charitable trust income application permits verified capital expenditure but rejects deferred pre-operative claims and requires reconsideration of con...
Reinsurance premium deductions require established regulatory breaches, while independently acquired software qualifies within the computer depreciati...
Rectification of mistake remains limited to self-evident record errors, preventing merits review through miscellaneous applications and preserving fin...
Tender creditworthiness conditions may extend to de facto Promoter Directors, with post-participation challenges generally barred absent arbitrariness...
Corporate representation in PMLA summons proceedings permitted through an authorised signatory, subject to directors' continuing cooperation and atten...
Exemption u/s 11 - rejection of assessee’s application for registration u/s 12A - The Appellate Tribunal found that the rejection of the application was unjustified as it was based on suspicion without credible material. It emphasized that at the registration stage, the focus should be on determining whether the objectives of the institution are charitable, rather than questioning the expenditure incurred. It was observed that while the Commissioner did not doubt the charitable nature of the institution's objectives, the rejection was primarily based on concerns about promoting pharmaceutical businesses. However, the Tribunal asserted that educating and raising awareness about diseases like endocrine disorders is inherently charitable.
Exemption u/s 11 - rejection of assessee’s application for registration u/s 12A - The Appellate Tribunal found that the rejection of the application was unjustified as it was based on suspicion without credible material. It emphasized that at the registration stage, the focus should be on determining whether the objectives of the institution are charitable, rather than questioning the expenditure incurred. It was observed that while the Commissioner did not doubt the charitable nature of the institution's objectives, the rejection was primarily based on concerns about promoting pharmaceutical businesses. However, the Tribunal asserted that educating and raising awareness about diseases like endocrine disorders is inherently charitable.
Note: It is a system-generated summary and is for quick reference only.